Bazex-Dupre-Christol syndrome
diseaseOn this page
Also known as acrokeratosis of Bazexacrokeratosis paraneoplasticaacrokeratosis paraneoplastica of BazexBazex syndromeBazex syndrome, X-linked dominantBazex-Dupré-Christol syndromeBDCSBZXfollicular atrophoderma and basal cell carcinomasfollicular atrophoderma-basal cell carcinoma syndromefollicular atrophoderma-basocellular proliferations-hypotrichosis syndrome
Summary
Bazex-Dupre-Christol syndrome (MONDO:0010535) is a disease. A subtype of skin disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- ClinVar variants: 1
- Phenotypes (HPO): 15
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 143 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
15 HPO clinical features (Orphanet curated; top 15 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0002208 | Coarse hair | Very frequent (80-99%) |
| HP:0001056 | Milia | Frequent (30-79%) |
| HP:0001482 | Subcutaneous nodule | Frequent (30-79%) |
| HP:0002209 | Sparse scalp hair | Frequent (30-79%) |
| HP:0002671 | Basal cell carcinoma | Frequent (30-79%) |
| HP:0003777 | Pili torti | Frequent (30-79%) |
| HP:0008070 | Sparse hair | Frequent (30-79%) |
| HP:0009886 | Trichorrhexis nodosa | Frequent (30-79%) |
| HP:0045075 | Sparse eyebrow | Frequent (30-79%) |
| HP:0200102 | Sparse or absent eyelashes | Frequent (30-79%) |
| HP:0000400 | Macrotia | Occasional (5-29%) |
| HP:0000889 | Abnormality of the clavicle | Occasional (5-29%) |
| HP:0001167 | Abnormality of finger | Occasional (5-29%) |
| HP:0100720 | Hypoplasia of the ear cartilage | Occasional (5-29%) |
| HP:0100777 | Exostoses | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Bazex-Dupre-Christol syndrome |
| Mondo ID | MONDO:0010535 |
| OMIM | 301845 |
| Orphanet | 113, 166113 |
| SNOMED CT | 238640007, 254820002 |
| UMLS | C0346104 |
| MedGen | 87539 |
| GARD | 0000838 |
| Is cancer (heuristic) | no |
Also known as: acrokeratosis of Bazex · acrokeratosis paraneoplastica · acrokeratosis paraneoplastica of Bazex · Bazex syndrome · Bazex syndrome, X-linked dominant · Bazex-Dupre-Christol syndrome · Bazex-Dupré-Christol syndrome · BDCS · BZX · follicular atrophoderma and basal cell carcinomas · follicular atrophoderma-basal cell carcinoma syndrome · follicular atrophoderma-basocellular proliferations-hypotrichosis syndrome
Data availability: 1 ClinVar variant.
Disease family
This is a subtype of skin disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › Bazex-Dupre-Christol syndrome
Related subtypes (71): dermatitis, cutaneous mucinosis, skin neoplasm, pyoderma, chronic ulcer of skin, systemic sclerosis, sunburn, severe cutaneous adverse reaction, paronychia, Achenbach syndrome, erythema multiforme, erythematosquamous dermatosis, exanthem, facial dermatosis, hand dermatosis, keratosis, leg dermatosis, lichen disease, lipodystrophy, mongolian spot, reactive cutaneous fibrous lesion, rosacea, scalp dermatosis, sebaceous gland disorder, skin atrophy, skin sarcoidosis, sweat gland disorder, vesiculobullous skin disease, hyperglobulinemic purpura, ainhum, cheilitis glandularis, erythema palmare hereditarium, multiple benign circumferential skin creases on limbs, actinic prurigo, congenital lethal erythroderma, Parana hard-skin syndrome, nephrogenic systemic fibrosis, erosive pustular dermatosis of the scalp, pseudoxanthoma elasticum-like papillary dermal elastolysis, toxic dermatosis, oral erosive lichen, chronic actinic dermatitis, Jessner lymphocytic infiltration of the skin, acquired kinky hair syndrome, primary cutaneous plasmacytosis, cutaneous pseudolymphoma, corticosteroid-sensitive aseptic abscess syndrome, interstitial granulomatous dermatitis with arthritis, epidermal disease, skin pigmentation disorder, skin vascular disease, Wells syndrome, solar urticaria, pellagra, hereditary epidermal appendage anomaly, keratosis pilaris, dermis disorder, aquagenic pruritus, Boudhina Yedes Khiari syndrome, non-neoplastic nevus, cutaneous sclerosis, pityriasis rotunda, hematohidrosis, skin disorder caused by infection, livedoid vasculopathy, prurigo nodularis, granuloma faciale, sclerema neonatorum, hereditary skin disorder, hand-foot syndrome, Nicolau syndrome
Subtypes (1): follicular atrophoderma-basal cell carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
1 retrieved; paginated sample, class counts are floors:
1 pathogenic
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 4277363 | Single allele | Pathogenic | criteria provided, single submitter |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.